Literature DB >> 23229830

Increased level of platelet P-selectin in nonarteritic anterior ischemic optic neuropathy.

Valeria Nagy1, Bence Kolozsvari, Zsuzsa Balogh, Adrienne Csutak, Marta Kasza, Bela Nagy, Laszlo Kardos, Andras Berta, Gyorgy Pfliegler.   

Abstract

PURPOSE: P-selectin receptor is expressed in platelets and endothelial cells in a cell-activation-dependent manner. Platelet P-selectin (CD62) levels may become elevated in a number of vasoocclusive diseases, including arteriosclerosis, atherothrombosis, and diabetes mellitus (DM). Nonarteritic anterior ischemic optic neuropathy (NAION) is associated with a sudden loss of vision due to the vascular insufficiency of ciliary arteries supplying the optic nerve. In this study, our aim was to investigate the presence of increased platelet reactivity in the development of NAION.
METHODS: Twenty-one NAION patients, 39 healthy control subjects, and 44 patients suffering from diabetes mellitus (DM) were examined in our case-control, pilot study. Platelet activation was investigated by flow cytometric analysis of the mean fluorescence intensity (MFI) of CD62 on platelets. These results were compared among the different study groups.
RESULTS: NAION patients showed considerably although not significantly (p = 0.2017) higher P-selectin MFI values (71.98 ± 40.30) versus healthy subjects (55.48 ± 20.95), insulin-dependent DM patients (50.02 ± 13.08), and non-insulin-dependent DM subjects (54.72 ± 24.74). However, logistic regression analysis resulted in a statistically significant adjusted effect on the odds of NAION when CD62 MFI values were logarithmically transformed (OR: 3.86, 95 % CI: 1.10 to 13.53, p = 0.0346).
CONCLUSION: Elevated platelet CD62 positivity may be related to NAION, suggesting a possible role of enlarged platelet activity in the generation of this type of ischemic optic neuropathy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23229830     DOI: 10.1007/s00417-012-2196-0

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  37 in total

1.  Risk stratification of emergency department patients with acute coronary syndromes using P-selectin.

Authors:  J E Hollander; M R Muttreja; M R Dalesandro; F S Shofer
Journal:  J Am Coll Cardiol       Date:  1999-07       Impact factor: 24.094

2.  Platelet P-selectin facilitates atherosclerotic lesion development.

Authors:  Peter C Burger; Denisa D Wagner
Journal:  Blood       Date:  2002-12-12       Impact factor: 22.113

3.  Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease.

Authors:  Ute Klinkhardt; Rupert Bauersachs; Jan Adams; Jochen Graff; Edeltraud Lindhoff-Last; Sebastian Harder
Journal:  Clin Pharmacol Ther       Date:  2003-03       Impact factor: 6.875

4.  Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: enhanced inhibitory effects of combination therapy.

Authors:  K Moshfegh; M Redondo; F Julmy; W A Wuillemin; M U Gebauer; A Haeberli; B J Meyer
Journal:  J Am Coll Cardiol       Date:  2000-09       Impact factor: 24.094

5.  Circulating platelets show increased activation in patients with acute cerebral ischemia.

Authors:  J A Zeller; D Tschoepe; C Kessler
Journal:  Thromb Haemost       Date:  1999-03       Impact factor: 5.249

Review 6.  Treatment of nonarteritic anterior ischemic optic neuropathy.

Authors:  Edward J Atkins; Beau B Bruce; Nancy J Newman; Valérie Biousse
Journal:  Surv Ophthalmol       Date:  2010 Jan-Feb       Impact factor: 6.048

7.  Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure.

Authors:  Irene Chung; Anirban Choudhury; Jeetesh Patel; Gregory Y H Lip
Journal:  Ann Med       Date:  2009       Impact factor: 4.709

8.  Increased platelet aggregation and activation in peripheral arterial disease.

Authors:  P A Robless; D Okonko; P Lintott; A O Mansfield; D P Mikhailidis; G P Stansby
Journal:  Eur J Vasc Endovasc Surg       Date:  2003-01       Impact factor: 7.069

9.  Activated protein C resistance in anterior ischaemic optic neuropathy.

Authors:  Valeria Nagy; Andrea Facsko; Lili Takacs; Erzsebet Balazs; Andras Berta; Istvan Balogh; Istvan Edes; Istvan Czuriga; Gyorgy Pfliegler
Journal:  Acta Ophthalmol Scand       Date:  2004-04

10.  Serum levels of soluble P-selectin are increased and associated with disease activity in patients with Behçet's syndrome.

Authors:  Yusuf Turkoz; Cem Evereklioglu; Abdullah Ozkiriş; Selçuk Mistik; Murat Borlu; Ibrahim H Ozerol; Fuat Duygulu; Ozgür Ilhan
Journal:  Mediators Inflamm       Date:  2005-08-31       Impact factor: 4.711

View more
  3 in total

1.  Effect of Humanin G (HNG) on inflammation in age-related macular degeneration (AMD).

Authors:  Sonali Nashine; Pinchas Cohen; Junxiang Wan; M Cristina Kenney
Journal:  Aging (Albany NY)       Date:  2022-05-16       Impact factor: 5.955

2.  Mean Platelet Volume in Patients with Nonarteritic Anterior Ischemic Optic Neuropathy.

Authors:  Muhammed Şahin; Alparslan Şahin; Bilal Elbey; Harun Yüksel; Fatih Mehmet Türkcü; Abdullah Kürşat Cingü
Journal:  J Ophthalmol       Date:  2016-02-04       Impact factor: 1.909

3.  Soluble P-selectin promotes retinal ganglion cell survival through activation of Nrf2 signaling after ischemia injury.

Authors:  Kishan Kapupara; Yao-Tseng Wen; Rong-Kung Tsai; Shun-Ping Huang
Journal:  Cell Death Dis       Date:  2017-11-16       Impact factor: 8.469

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.